Related Experiment Video
Updated: Nov 3, 2025

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists
Robert Adam1,2, Gabriela Neculae1, Claudiu Stan2,3
1Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, "Prof. Dr. C.C. Iliescu" Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania.
Insights
Cardiac amyloidosis (CA) is increasingly recognized, yet Romanian cardiologists show varied knowledge and limited experience. Educational initiatives are crucial to improve early diagnosis and treatment of this condition.
Area of Science:
- Cardiology
- Amyloidosis Research
- Medical Education
Background:
- Cardiac amyloidosis (CA) is a restrictive cardiomyopathy caused by amyloid deposition in the heart muscle.
- Recent studies indicate CA is more prevalent than previously thought.
- Advances in diagnosis and treatment necessitate prompt identification of CA.
Purpose of the Study:
- To assess the current knowledge and experience of Romanian cardiologists regarding cardiac amyloidosis.
- To identify gaps in understanding CA, including specific types like transthyretin amyloidosis (ATTRwt and ATTRv).
- To highlight educational needs for improving CA diagnosis and management.
Main Methods:
- An online survey was distributed to cardiologists in Romania.
- 195 cardiologists completed the questionnaire on their knowledge and experience with CA.
- The survey assessed awareness of CA prevalence, diagnosis, and treatment options.
Main Results:
- Significant variation in knowledge about CA was observed among participants.
- Romanian cardiologists reported limited experience with CA and noted delays in diagnosis.
- Gaps were identified in understanding ATTRwt and ATTRv prevalence, diagnosis, and treatment.
Conclusions:
- Cardiologist awareness is a key challenge in diagnosing CA.
- Romanian cardiologists possess partial awareness but require further education on CA.
- Targeted educational programs can enhance patient screening and improve outcomes for CA.
Abstract:
Cardiac amyloidosis (CA) is a restrictive cardiomyopathy characterized by deposition of amyloid in the myocardium and recent studies revealed it is more frequently seen than we thought. Advances in diagnosis and treatment have been made over the last few years that make it desirable to diagnose CA without delay, and that may require extra education. An online survey was conducted among cardiologists from Romania, representing the first assessment of the knowledge of CA among them, with 195 cardiologists answering the questionnaire. There was a wide variation in their knowledge regarding CA. Our participants had limited experience with CA and reported a significant delay between first cardiac symptoms and diagnosis. We address the gaps in knowledge that were identified as educational opportunities in the main identified areas: prevalence and treatment of wild type transthyretin amyloidosis (ATTRwt), prevalence of variant transthyretin amyloidosis (ATTRv) in Romania, diagnosis of CA, the delay in CA diagnosis and available treatment options. Awareness among cardiologists is the most important challenge in diagnosing CA. Romanian cardiologists are partially aware of this topic, but there are still gaps in their knowledge. Educational programs can improve screening of patients with a high suspicion for this progressive condition the prognosis of which has been dramatically changed by the new treatment options.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VI: Nursing Management

